Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
US9308204B2 · kind B2 · utility
0Cited by
55References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 7, 2014 |
| Grant date | Apr 12, 2016 |
| Priority date | — |
| Expiry date | Nov 7, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (A) and (B) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.